Vaccinia Virus
Vaccinia virus is a member of the Orthopoxvirus genus, which also includes smallpox virus, monkeypox virus, and cowpox virus. It is a large, enveloped DNA virus that replicates in the cytoplasm of infected cells. Vaccinia virus has been extensively studied as a model virus for poxvirus research and has been used as a vaccine to protect against smallpox. Vaccinia virus has a complex genome consisting of approximately 200 genes that encode for a variety of proteins involved in viral replication, host immune evasion, and host cell interactions. The virus is capable of infecting a wide range of host species, including humans, but is generally not pathogenic in healthy individuals. One of the key features of vaccinia virus is its ability to induce a strong and long-lasting immune response. This property has made it an important tool in the development of vaccines for a variety of infectious diseases. Recent research has shown that vaccinia virus may also have potential as an oncolytic virus, meaning that it can selectively infect and kill cancer cells. This property is thought to be due to the virus's ability to replicate in and lyse rapidly dividing cells. Overall, vaccinia virus is a fascinating and important virus with a long history of use in basic research and vaccine development. Its potential as an oncolytic virus also suggests that it may have clinical applications beyond its original use as a smallpox vaccine.
←